Interestingly, SE activity nearby the cyclin‐dependent kinase inhibitor 1 gene CDKN1A (encoding p21) was reduced in CLL, which has been reported to be a p53‐independent tumor suppressor (Abbas & Dutta, 2009). This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.